仅用于工业应用或科学研究,不可用于人类或动物的临床诊断或治疗,非药用. Sutimlimab, a first-in-class complement protein component 1, s subcomponent (C1s) inhibitor, can be used for the research of cold agglutinin disease. C1s is a serine protease which cleaves C4 and C2 to form the C3 convertase